Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) Leases (2017 - 2025)

Organogenesis Holdings has reported Leases over the past 9 years, most recently at $55.7 million for Q4 2025.

  • Quarterly results put Leases at $55.7 million for Q4 2025, up 50.23% from a year ago — trailing twelve months through Dec 2025 was $55.7 million (up 50.23% YoY), and the annual figure for FY2025 was $55.7 million, up 50.23%.
  • Leases for Q4 2025 was $55.7 million at Organogenesis Holdings, up from $33.3 million in the prior quarter.
  • Over the last five years, Leases for ORGO hit a ceiling of $55.7 million in Q4 2025 and a floor of $2.1 million in Q2 2023.
  • Median Leases over the past 5 years was $37.9 million (2024), compared with a mean of $37.1 million.
  • Biggest five-year swings in Leases: plummeted 95.41% in 2023 and later surged 1636.56% in 2024.
  • Organogenesis Holdings' Leases stood at $49.1 million in 2021, then fell by 12.11% to $43.2 million in 2022, then decreased by 7.12% to $40.1 million in 2023, then dropped by 7.5% to $37.1 million in 2024, then surged by 50.23% to $55.7 million in 2025.
  • The last three reported values for Leases were $55.7 million (Q4 2025), $33.3 million (Q3 2025), and $35.3 million (Q2 2025) per Business Quant data.